Skip to main content
Erschienen in: Journal of Clinical Monitoring and Computing 1/2015

01.02.2015 | Commentary

4Ts scoring with hemofiltration or hemodialysis clotting

verfasst von: Theodore E. Warkentin

Erschienen in: Journal of Clinical Monitoring and Computing | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

In this issue of Journal of Clinical Monitoring and Computing, Perbet et al. [1] report 2 intensive care unit (ICU) patients with hemofiltration filter clotting associated with heparin-induced thrombocytopenia (HIT), an immune-mediated prothrombotic adverse drug reaction [2, 3]. In both patients, early (within 6 h) hemofilter thrombosis occurred at a time when the patients were not thrombocytopenic. The authors propose that hemofilter clotting should be considered a thrombotic event in the 4Ts scoring system (discussed subsequently), even in the absence of thrombocytopenia. The authors specifically suggest [1] that rapid hemofiltration clotting should score as 2 points for the category, Thrombosis, in this scoring system. …
Literatur
1.
Zurück zum Zitat Perbet S, Goet T, Lebreton A, Sapin AF, Constantin JM. Repeated early hemofiltration filters clotting and heparin-induced thrombocytopenia in ICU. J Clin Monit Comput. 2014. doi:10.1007/s10877-014-9589-z. Perbet S, Goet T, Lebreton A, Sapin AF, Constantin JM. Repeated early hemofiltration filters clotting and heparin-induced thrombocytopenia in ICU. J Clin Monit Comput. 2014. doi:10.​1007/​s10877-014-9589-z.
2.
Zurück zum Zitat Warkentin TE. Drug-induced immune-mediated thrombocytopenia—from purpura to thrombosis. N Engl J Med. 2007;356(9):891–3.PubMedCrossRef Warkentin TE. Drug-induced immune-mediated thrombocytopenia—from purpura to thrombosis. N Engl J Med. 2007;356(9):891–3.PubMedCrossRef
3.
Zurück zum Zitat Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Crit Care Clin. 2011;27(4):805–23.PubMedCrossRef Warkentin TE. Heparin-induced thrombocytopenia in critically ill patients. Crit Care Clin. 2011;27(4):805–23.PubMedCrossRef
4.
Zurück zum Zitat Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–65.PubMedCrossRef Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost. 2006;4(4):759–65.PubMedCrossRef
5.
Zurück zum Zitat Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T’s score. J Thromb Haemost. 2010;8(7):1483–5.PubMedCrossRef Warkentin TE, Linkins LA. Non-necrotizing heparin-induced skin lesions and the 4T’s score. J Thromb Haemost. 2010;8(7):1483–5.PubMedCrossRef
6.
Zurück zum Zitat McMahon CM, Cuker A. The 4Ts test in the critically ill: timing is everything. J Crit Care. 2014;29(3):468–9.PubMedCrossRef McMahon CM, Cuker A. The 4Ts test in the critically ill: timing is everything. J Crit Care. 2014;29(3):468–9.PubMedCrossRef
7.
Zurück zum Zitat Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2012;120(20):4160–7.PubMedCentralPubMedCrossRef Cuker A, Gimotty PA, Crowther MA, Warkentin TE. Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis. Blood. 2012;120(20):4160–7.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansell D, McIntrye L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Kwaja K, Sheppard JA, Warkentin TE. For the PROTECT collaborators, the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial. J Crit Care. 2014;23(3):470.e7–15.CrossRef Crowther M, Cook D, Guyatt G, Zytaruk N, McDonald E, Williamson D, Albert M, Dodek P, Finfer S, Vallance S, Heels-Ansell D, McIntrye L, Mehta S, Lamontagne F, Muscedere J, Jacka M, Lesur O, Kutsiogiannis J, Friedrich J, Klinger JR, Qushmaq I, Burry L, Kwaja K, Sheppard JA, Warkentin TE. For the PROTECT collaborators, the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial. J Crit Care. 2014;23(3):470.e7–15.CrossRef
9.
Zurück zum Zitat Lanquetot H, Leprince T, Ragot S, Boinot C, Jayle C, Robert R, Macchi L. Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass. Intensive Care Med. 2008;34(11):2068–75.PubMedCrossRef Lanquetot H, Leprince T, Ragot S, Boinot C, Jayle C, Robert R, Macchi L. Antithrombin level and circuit thrombosis during hemofiltration after cardiopulmonary bypass. Intensive Care Med. 2008;34(11):2068–75.PubMedCrossRef
10.
Zurück zum Zitat Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010;30(11):1117–26.PubMedCrossRef Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010;30(11):1117–26.PubMedCrossRef
11.
Zurück zum Zitat Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121(4):535–55.PubMedCrossRef Warkentin TE. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol. 2003;121(4):535–55.PubMedCrossRef
13.
Zurück zum Zitat Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med. 2003;163(20):2518–24.PubMedCrossRef Warkentin TE, Roberts RS, Hirsh J, Kelton JG. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med. 2003;163(20):2518–24.PubMedCrossRef
14.
Zurück zum Zitat Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101(5):502–7.PubMedCrossRef Warkentin TE, Kelton JG. A 14-year study of heparin-induced thrombocytopenia. Am J Med. 1996;101(5):502–7.PubMedCrossRef
15.
Zurück zum Zitat Tang IY, Cox DS, Patel K, Reddy BV, Nahlik L, Trevino S, Murray PT. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Ann Pharmacother. 2005;39(2):231–6.PubMedCrossRef Tang IY, Cox DS, Patel K, Reddy BV, Nahlik L, Trevino S, Murray PT. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Ann Pharmacother. 2005;39(2):231–6.PubMedCrossRef
16.
Zurück zum Zitat Lasocki S, Piednoir P, Aizenberg N, Geffroy A, Benbara A, Montravers P. Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study. Crit Care. 2008;12(3):R84.PubMedCentralPubMedCrossRef Lasocki S, Piednoir P, Aizenberg N, Geffroy A, Benbara A, Montravers P. Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study. Crit Care. 2008;12(3):R84.PubMedCentralPubMedCrossRef
Metadaten
Titel
4Ts scoring with hemofiltration or hemodialysis clotting
verfasst von
Theodore E. Warkentin
Publikationsdatum
01.02.2015
Verlag
Springer Netherlands
Erschienen in
Journal of Clinical Monitoring and Computing / Ausgabe 1/2015
Print ISSN: 1387-1307
Elektronische ISSN: 1573-2614
DOI
https://doi.org/10.1007/s10877-014-9594-2

Weitere Artikel der Ausgabe 1/2015

Journal of Clinical Monitoring and Computing 1/2015 Zur Ausgabe

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Ärztliche Empathie hilft gegen Rückenschmerzen

23.04.2024 Leitsymptom Rückenschmerzen Nachrichten

Personen mit chronischen Rückenschmerzen, die von einfühlsamen Ärzten und Ärztinnen betreut werden, berichten über weniger Beschwerden und eine bessere Lebensqualität.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.